Takeda Offers $2.2 Billion Actos Settlement
Takeda Pharmaceuticals, manufacturer of Actos, is willing to pay $2.2 billion to resolve claims that it concealed cancer risks linked to its diabetes medicine. The proposed Actos settlement, if accepted by plaintiffs, would mark one of the largest U.S. accords of patient lawsuits involving pharmaceutical... Read More